Editorial

Updates of CSCO guidelines for colorectal cancer version 2025
Demin Lu, Caixia Dong, Kailai Wang, Chenyang Ye, Liubo Chen, Ying Yuan, Hanguang Hu

Original Article

Deep learning-based differentiation of benign and malignant thyroid follicular neoplasms on multiscale intraoperative frozen pathological images: A multicenter diagnostic study
Jiahui Liu, Chuanguang Xiao, Haicheng Zhang, Pengyi Yu, Qi Wang, Ziru Peng, Guohua Yu, Ping Yang, Yakui Mou, Chuanliang Jia, Hongxia Cheng, Ning Mao, Xicheng Song
Multi-omics profile of exceptional long-term survivors of AJCC stage III triple-negative breast cancer
Yang Ou-Yang, Caijin Lin, Yifan Xie, Xiaoqing Song, Yi-Zhou Jiang
Comparison of efficacy and safety of a proposed biosimilar QL1206 with reference denosumab in patients with bone metastasis from breast cancer: A subgroup analysis of a randomized, double-blinded phase III study
Yaxin Liu, Ruyan Zhang, Xiaojia Wang, Lijun Di, Zhendong Chen, Jingfen Wang, Tao Sun, Qingshan Li, Jing Cheng, Qingyuan Zhang, Xiuwen Wang, Junye Wang, Kangsheng Gu, Shihong Wei, Shuqun Zhang, Xiangcai Wang, Ping Sun, Chunfang Hao, Aimin Zang, Yujie Li, Cuicui Han, Xiaoyan Kang, Yanling Li, Huiping Li
Evaluation of two algorithms measuring homologous recombination deficiency status in prognostic assessment for treatment-naïve non-small cell lung cancer
Yidan Ma, Jingyu Huang, Lei He, Jun Du, Longteng Liu, Xiaoguang Li, Peng Jiao, Xiaonan Wu, Wei Zhou, Xiaomao Xu, Li Yang, Jing Di, Changbin Zhu, Lin Li, Dongge Liu, Zheng Wang
Long-term outcomes of laparoscopic distal gastrectomy for locally advanced gastric cancer: An individual patient data meta-analysis of KLASS-02 and CLASS-01 randomized controlled trials
Yanfeng Hu, Woo Jin Hyung, Huilin Huang, Changming Huang, Han-Kwang Yang, Yihong Sun, Young-Kyu Park, Xiangqian Su, Hyuk-Joon Lee, Hui Cao, Ji Yeong An, Jiankun Hu, Wook Kim, Kuan Wang, Hyoung-Il Kim, Jian Suo, Hyung-Ho Kim, Kaixiong Tao, Seung Wan Ryu, Xianli He, Hoon Hur, Hongbo Wei, Min-Chan Kim, Seong-Ho Kong, Mingang Ying, Gyu Seok Cho, Weiguo Hu, Jin-Jo Kim, Xiaohui Du, Do Joong Park, Jiang Yu, Keun Won Ryu, Hao Liu, Young Woo Kim, Ziyu Li, Jong Won Kim, Jiafu Ji, Joo-Ho Lee, Guoxin Li, Sang-Uk Han
Development and validation of machine learning-based survival analysis to predict outcome in gastric cancer with adjuvant chemotherapy: A multicenter, longitudinal, cohort study
Yan Pan, Linbin Lu, Xianchun Gao, Jun Yu, Sitian Dai, Ruirong Yao, Ning Han, Xinlin Wang, Abudurousuli Reyila, Shibo Wang, Junya Yan, Zhen Xu, Yuanyuan Lu, Mengbin Li, Jipeng Li, Jiayun Liu, Qingchuan Zhao, Kaichun Wu, Yongzhan Nie
Potential impact of controlling risk factors on future liver cancer deaths in China
Mengdi Cao, Yi Teng, Qianru Li, Nuopei Tan, Jiachen Wang, Tingting Zuo, Tianyi Li, Yuanjie Zheng, Changfa Xia, Wanqing Chen
Discovery and validation of indole nitroolefins as novel covalent GPX4 inhibitors for inducing ferroptosis in urological cancers
Na Zeng, Guichen Ye, Mengchu Zheng, Guangyuan Liu, Sihan Zhang, Siyang Ma, Zhiyu Xia, Yirong Zhou, Shaogang Wang, Qidong Xia
Venetoclax and azacitidine compared with intensive chemotherapy for adverse-risk acute myeloid leukemia patients receiving allogeneic hematopoietic stem cell transplantation in first complete remission: A multicenter study of TROPHY group
Qi Wen, Chuanhe Jiang, Xiaodan Liu, Yi Xia, Yilei Ma, Yang Yang, Yu Wang, Yingjun Chang, Luxiang Wang, Zilu Zhang, Xiaojun Huang, Yang Cao, Yanmin Zhao, Xiaoxia Hu, Xiaodong Mo

Review Article

Immune cell metabolism in cancer drug resistance: Advances in target discovery and clinical translation
Liangjie Sun, Guo Zhao, Shuhang Wang, Ning Li
Tumor-educated cells in tumor microenvironment: Key drivers of immunotherapy resistance
Ji’an Zou, Shuxing Wang, Yingzhe Zhang, Wentao Tian, Ge Mai, Yiting Xu, Wenjie Xiao, Edward E. Graves, Fang Wu
Molecular insights into immune evasion and therapeutic paradigms in pancreatic cancer
Ming Li, Renyu Zhou, Yu Qiu, Yulong Peng, Minting Liu, Xiaotan Zhang

CSCO Guidelines

CSCO guidelines for colorectal cancer version 2024: Updates and discussions
Liubo Chen, Hanguang Hu, Ying Yuan, Shanshan Weng
CSCO guidelines for colorectal cancer version 2023: Updates and insights
Mi Mi, Shanshan Weng, Ziheng Xu, Hanguang Hu, Yi Wang, Ying Yuan
CSCO guidelines for colorectal cancer version 2022: Updates and discussions
Zhijun Yuan, Shanshan Weng, Chenyang Ye, Hanguang Hu, Suzhan Zhang, Ying Yuan
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version)
Jun Zhu, Jun Ma, Union for China Lymphoma Investigators of Chinese Society of Clinical Oncology
Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020
Caixia Dong, Yuwei Ding, Shanshan Weng, Guichao Li, Yanqing Huang, Hanguang Hu, Zhen Zhang, Suzhan Zhang, Ying Yuan
Updates in version 2020 of CSCO guidelines for colorectal cancer from version 2019
Shanshan Weng, Ying Yuan, Xicheng Wang, Gong Chen, Yi Wang, Weiqi Sheng, Xinxiang Li, Aiping Zhou, Zhen Zhang, Guichao Li, Sanjun Cai, Ruihua Xu, Jin Li, Suzhan Zhang
Updates in version 2019 of CSCO guidelines for colorectal cancer from version 2018
Ying Yuan, Xicheng Wang, Gong Chen, Yi Wang, Weiqi Sheng, Xinxiang Li, Aiping Zhou, Zhen Zhang, Guichao Li, Sanjun Cai, Ruihua Xu, Jin Li, Suzhan Zhang
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer 2018 (English version)
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer working group
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer 2018 (English version)
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer working group
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version)
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer working group

NHCPRC Guidelines

National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China (English version)
National Health Commission of the People’s Republic of China; Society of Oncology, Chinese Medical Association
National guidelines for diagnosis and treatment of malignant lymphoma 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of esophageal carcinoma 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of melanoma 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of lung cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of gastric cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of colorectal cancer 2020 in China (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of melanoma 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of malignant lymphoma 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of breast cancer 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of pancreatic cancer 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of cervical cancer 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of primary lung cancer 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of renal cell carcinoma 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of urothelial carcinoma of bladder 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of prostate cancer 2018 (English version)
National Health Commission of the People’s Republic of China

Guidelines

Management guidelines for preventing exposure to antineoplastics
Wei Liu, Ziyang Wu, Tong Sun, Shuyao Liang, Jun Zhu, Suodi Zhai, Division of Therapeutic Drug Monitoring of Chinese Pharmacological Society, Hospital Pharmacy Professional Committee of Chinese Pharmaceutical Association, Oncology Society of Chinese Medical Association, Nursing Branch of China International Exchange and Promotive Association for Medical and Healthcare, Division of Drug-induced Diseases of Chinese Pharmacology Society